Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
FibroGen, Inc. is a biotechnology-based drug discovery company using its expertise in the fields of tissue fibrosis, connective tissue growth factor (CTGF), and hypoxia-inducible factor (HIF) biology to discover, develop, and commercialize novel therapeutics for fibrotic disorders, diabetic complications, anemia, conditions associated with tissue damage or injury, cancer, and other areas of unmet medical need. FibroGen also develops and produces recombinant human collagens and gelatins using unique production technology that provides the basis for FibroGen’s proprietary cosmetic dermal filler and biomaterials supply business. ( www.fibrogen.com )
FibroGen , Inc.
225 Gateway Blvd.
South San Francisco, California 94080
USA
Tel: (650) 866-7200
Fax: (650) 866-7201